Natural Beauty Bio-Technology Limited provided earnings guidance for the six months ended 30 June 2022. For the period, the Group is expected to record a net loss of approximately HKD 30.2 million for the six months ended 30 June 2022. The increase of HKD 6.6 million in the amount of expected net loss as compared to the figure previously announced in the Announcement is primarily attributable to an impairment loss on the goodwill, property, plant and equipment owing to the cessation of business of the cash generating unit (CGU) of medical aesthetics services operated by Beijing Jiayun Medical Beauty Clinic Company Limited, one of the subsidiaries of the Group due to an unsuccessful renewal of its practice license of medical institution in the PRC, which came to the notice of the management of the Group subsequent to the publication of the Announcement.